Stemline Therapeutics, Inc. 401(K) Plan — Form 5500 plan (Stemline Therapeutics, Inc.)

Plain-English plan summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Stemline Therapeutics, Inc. 401(K) Plan is a benefit plan reported by Stemline Therapeutics, Inc. under EIN 45-0522567 and plan number 001. The latest loaded filing year is 2023. The filing reports 269 participants and $23,535,996 in end-of-year plan assets, where available in the loaded dataset.

Key reported metrics

Plan sponsor
Stemline Therapeutics, Inc.
EIN
45-0522567
Plan number
001
Plan type
2
Location
New York, NY
Latest filing year
2023
Participants
269
End-of-year plan assets
$23,535,996

Form 5500 filing history

Filings loaded for this plan
Filing yearParticipantsSchedulesFiling
2023269H, C20241015123209NAL0056145730003

Reported financial statement (2023 · Schedule H)

Net assets

Total assets (EOY)
$23,535,996
Net assets (EOY)
$23,535,996
Net assets (BOY)
$11,982,170

Income & contributions

Employer contributions
$2,686,806
Participant contributions
$5,437,984
Total contributions
$10,356,321
Total income / additions
$13,529,636

Expenses & distributions

Benefits paid
$1,921,250
Administrative expenses
$8,751
Total expenses
$1,975,810
Net increase / (decrease)
$11,553,826

Service provider compensation (Schedule C)

Reported service provider compensation
ProviderServiceDirect comp.Indirect comp.Year
Wilshire AssociatesINVESTMENT ADVISOR$7,877not reported in the loaded dataset2023
Insperity Retirement ServicesRECORDKEEPER$2,300not reported in the loaded dataset2023

Related Form 5500 pages